Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2561 – 2580 of 3231

Preventing HIV Transmission During Infant Feeding

https://clinicalinfo.hiv.gov/guidelines/perinatal/preventing-transmission-infant-feeding

Appendix D. Financial Disclosures

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-financial-disclosures

Appendix A: Sample Short Intake Form for People With HIV Who Are Seeking Care

https://clinicalinfo.hiv.gov/guidelines/guidance-hiv-disasters/appendix-sample-short-intake-form

Nevirapine (Viramune, NVP)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-nevirapine-viramune

Table 3. Indications for Discontinuing and Restarting Primary and Secondary Prophylaxis (or Chronic Maintenance Therapy) for Selected Opportunistic Infections in Adults and Adolescents with HIV

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/indications-discontinuing-and

Special Populations: Early (Acute and Recent) HIV Infection

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-early-acute-recent-hiv-infection

Antiretroviral Pregnancy Registry

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-pregnancy-registry

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/what-start

Rilpivirine (Edurant, RPV)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-rilpivirine-edurant

Lipodystrophies and Weight Gain

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/lipodystrophies-and-weight-gain

Financial Disclosure

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/financial-disclosure

Tenofovir Alafenamide (Vemlidy, TAF)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-tenofovir-alafenamide-vemlidy

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/syphilis

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/doravirine

Drug Abbreviations

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/drug-abbreviations

Pneumocystis Pneumonia

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/pneumocystis

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/bictegravir

Financial Disclosure

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/financial-disclosure

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/hepatic-events

When to Initiate Antiretroviral Treatment in Children With HIV Infection

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/when-initiate-therapy-antiretroviral-naive-children